Article Versions Notes

Parrera GS, Astacio H, Tunga P, Anderson DM, Hall CL, Richardson JS. Use of Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G)—(Equine) (BAT^®) in Clinical Study Subjects and Patients: A 15-Year Systematic Safety Review. Toxins. 2022; 14(1):19. https://doi.org/10.3390/toxins14010019

Parrera, Geraldine S., Hugo Astacio, Priya Tunga, Deborah M. Anderson, Christine L. Hall, and Jason S. Richardson. 2022. "Use of Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G)—(Equine) (BAT^®) in Clinical Study Subjects and Patients: A 15-Year Systematic Safety Review" Toxins 14, no. 1: 19. https://doi.org/10.3390/toxins14010019

Parrera, G. S., Astacio, H., Tunga, P., Anderson, D. M., Hall, C. L., & Richardson, J. S. (2022). Use of Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G)—(Equine) (BAT^®) in Clinical Study Subjects and Patients: A 15-Year Systematic Safety Review. Toxins, 14(1), 19. https://doi.org/10.3390/toxins14010019